top of page

Lilly hails Alzheimer's win with donanemab, boasting 'significant slowing of decline'

The amyloid theory continues to grasp at life as Eli Lilly has unveiled new phase 2 data that can help by clearing these plaques out of the brain.

13 views0 comments

Recent Posts

See All


bottom of page